- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment Options for Pancreatic Neuroendocrine Tumors
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 6, Pages 828
Publisher
MDPI AG
Online
2019-06-14
DOI
10.3390/cancers11060828
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Surufatinib in advanced well-differentiated neuroendocrine tumors: a multicenter, single-arm, open-label, phase Ib/II trial
- (2019) Jian Ming Xu et al. CLINICAL CANCER RESEARCH
- External Beam Radiotherapy in the Treatment of Gastroenteropancreatic Neuroendocrine Tumours: A Systematic Review
- (2018) D.L. Chan et al. CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018
- (2018) Manisha H. Shah et al. Journal of the National Comprehensive Cancer Network
- A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).
- (2018) Pamela L. Kunz et al. JOURNAL OF CLINICAL ONCOLOGY
- A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
- (2018) Guido Rindi et al. MODERN PATHOLOGY
- Current Management of Pancreatic Neuroendocrine Tumors: From Demolitive Surgery to Observation
- (2018) Ilenia Bartolini et al. Gastroenterology Research and Practice
- Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome
- (2017) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518
- (2017) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
- (2016) James C Yao et al. LANCET
- ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
- (2016) M. Falconi et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
- (2016) M. Pavel et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
- (2016) R. Garcia-Carbonero et al. NEUROENDOCRINOLOGY
- Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors
- (2015) Timothy J. Hobday et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study
- (2015) Alexandria T Phan et al. LANCET ONCOLOGY
- Perfusion Computed Tomography as Functional Biomarker in Randomized Run-In Study of Bevacizumab and Everolimus in Well-Differentiated Neuroendocrine Tumors
- (2015) James C. Yao et al. PANCREAS
- Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference
- (2015) Andrew Kennedy et al. HPB
- Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial) – A phase II non-randomised trial
- (2014) Michel Ducreux et al. EUROPEAN JOURNAL OF CANCER
- Severe resistant hypoglycemia in a patient with a pancreatic neuroendocrine tumor on sunitinib treatment
- (2014) Athanasios Fountas et al. Hormones-International Journal of Endocrinology and Metabolism
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors
- (2014) Stefano Crippa et al. SURGERY
- Therapeutic effect of sunitinib malate and its influence on blood glucose concentrations in a patient with metastatic insulinoma
- (2013) Jianpeng Chen et al. Expert Review of Anticancer Therapy
- Observational Study of Natural History of Small Sporadic Nonfunctioning Pancreatic Neuroendocrine Tumors
- (2013) Sébastien Gaujoux et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors
- (2013) Pamela L. Kunz et al. PANCREAS
- Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) K. Oberg et al. ANNALS OF ONCOLOGY
- Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy
- (2011) Staffan Welin et al. CANCER
- The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
- (2011) Ben Lawrence et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Improved Control of Severe Hypoglycemia in Patients with Malignant Insulinomas by Peptide Receptor Radionuclide Therapy
- (2011) E. van Schaik et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas
- (2010) Simona Grozinsky-Glasberg et al. CANCER
- First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas
- (2010) Jonathan R. Strosberg et al. CANCER
- Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
- (2008) T. R. Halfdanarson et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now